6 Followers on Owler
OverviewCompetitorsAcquisitionsFundingInvestmentsNews & Insights

Innoviva Competitors or Alternatives

Innoviva's top competitors include AstraZeneca, GSK and TEVA.

Unlock 4 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

Innoviva's company profile

Pavel Raifeld

CEO

90/100
100
$192.5M
$358.7M
  • $192.5M
    $358.7M
  • 100
    $192.5M
  • $358.7M
  • 90/100
  • 100
  • $192.5M
  • $358.7M
View ProfileView
1
Innoviva's Competitor - AstraZeneca logo

Pascal Soriot

CEO

72/100
89,900
$100M
$51.2B
  • $100M
    $51.2B
  • 89,900
    $100M
  • $51.2B
  • 72/100
  • 89,900
  • $100M
  • $51.2B
View ProfileView
2
Innoviva's Competitor - GSK logo

Dame Emma Walmsley

CEO

67/100
70,200
$2.3B
$41B
  • $2.3B
    $41B
  • 70,200
    $2.3B
  • $41B
  • 67/100
  • 70,200
  • $2.3B
  • $41B
View ProfileView
3
Innoviva's Competitor - TEVA logo

Richard Francis

President & CEO

82/100
36,830
$13.9B
$16.5B
  • $13.9B
    $16.5B
  • 36,830
    $13.9B
  • $16.5B
  • 82/100
  • 36,830
  • $13.9B
  • $16.5B
View ProfileView
4
Innoviva's Competitor - Boehringer Ingelheim logo

Paola Casarosa

Managing Director

74/100
50,000 - 100,000
- -
$10B - 50B
  • - -
    $10B - 50B
  • 50,000 - 100,000
    - -
  • $10B - 50B
  • 74/100
  • 50,000 - 100,000
  • - -
  • $10B - 50B
View ProfileView
5
Innoviva's Competitor - Novartis logo

Vasant Narasimhan

CEO

88/100
75,883
- -
$50.3B
  • - -
    $50.3B
  • 75,883
    - -
  • $50.3B
  • 88/100
  • 75,883
  • - -
  • $50.3B
View ProfileView
Innoviva's top 7 competitors are AstraZeneca, GSK, TEVA, Merck, Boehringer Ingelheim, Novartis and Chiesi. Together they have raised over 24.4B between their estimated 401.8K employees. Innoviva has 100 employees and is ranked 8th among it's top 10 competitors. The top 10 competitors average 50,239.

Innoviva VS AstraZeneca

AstraZeneca is the biggest rival of Innoviva. AstraZeneca is headquartered in Cambridge, England, and was founded in 1999. Like Innoviva, AstraZeneca also operates in the Pharmaceuticals space. AstraZeneca generates 14,275% the revenue of Innoviva.

Innoviva VS GSK

GSK is Innoviva's #2 competitor. GSK is a Public company that was founded in London, England in 2000. Like Innoviva, GSK also works within the Pharmaceuticals sector. GSK has 70,100 more employees vs. Innoviva.

Innoviva VS TEVA

TEVA has been one of Innoviva's top competitors. TEVA's headquarters is in Tel Aviv, Tel Aviv District, and was founded in 1901. TEVA operates in the Pharmaceuticals industry. TEVA generates 4,612% of Innoviva's revenue.

Looking for similar companies to Innoviva?

Similar Companies

Companies in Burlingame with revenue in $100-500M range

See 10 companies 
Pharmaceuticals companies in Burlingame

See 14 companies 
Companies in Burlingame with employees in 100-250 range

See 134 companies 
Pharmaceuticals & Biotechnology companies in Burlingame

See 33 companies 
Pharmaceuticals companies with revenue in $100-500M range

See 298 companies 
Pharmaceuticals companies in San Francisco Bay Area

See 512 companies 
Pharmaceuticals & Biotechnology companies with revenue in $100-500M range

See 569 companies 
Pharmaceuticals companies with employees in 100-250 range

See 813 companies 
Companies in San Francisco Bay Area with revenue in $100-500M range

See 860 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for Innoviva and Innoviva's Competitors

Today 7:13 AMBenzinga
NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potenti...
April 17, 2025The Korea Bizwire
Christian Boehringer to hand over as Chairman of the Shareholders' Committee to Hubertus von Baumbach Shashank Deshpande, Member of the Board of Managi...
April 17, 2025PMLiVE
Penmenvy combines the antigenic components of GSK's approved Bexsero and Menveo vaccines...
April 17, 2025Law 360
Not-for-profit insurance company EmblemHealth Inc. has hit an AstraZeneca unit with a proposed class action claiming the subsidiary defrauded the U.S. ...
April 17, 2025Bloomberg Law
A three-judge panel wrestled Thursday with Novartis AG's challenge against the FDA over its approval of a generic version of its heart failure drug, pr...
April 16, 2025PMLiVE
The deal gives Merck access to Cyprumed's drug delivery platform for an undisclosed number of targets...
April 17, 2025Pharamceutical Technology
The ACIP has voted to recommend the use of respiratory syncytial virus (RSV) vaccines for adults aged 50 to 59....
April 16, 2025Pharmabiz
Boehringer Ingelheim, a biopharmaceutical company active in both human and animal health, and Cue Biopharma, Inc., a clinical─stage biopharmaceutical c...
April 17, 2025Seeking Alpha
April 17, 2025Openpr
The global strep throat treatment market was valued at US$ 2.08 Bn in 2025 and is expected to reach US$ 2.85 Bn by 2032, growing at a compound annual g...

Frequently Asked Questions about Innoviva

  1. Who are Innoviva's top competitors?

    Innoviva's top 3 competitors are AstraZeneca, GSK, TEVA.

  2. Who is similar to Innoviva?

    AstraZeneca is the most similar to Innoviva. GSK and TEVA are also similar to Innoviva.

  1. Are Innoviva and AstraZeneca competitors?

    Yes, AstraZeneca is one of Innoviva’s top competitors.